Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-12002822Phase 4Completed
Phase 4, open-label trial of guifu dihuang pill in diabetic glomerulosclerosis (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Urine microalbumin excretion rate over 24 hours. Started Dec 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-12002822.